Hyogo CC

Akashi-shi

0 studies enrolling now · 1 studies all time

What they study most

Advanced Ovarian Cancer, BRCA Mutation, Complete Response, FIGO Stage III-IV, First Line Platinum Chemotherapy, Newly Diagnosed, Partial Response

Studies at this site

• Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy. — Running, not enrolling